Serum and intraerythrocyte antioxidant enzymes and lipid peroxides in children with migraine

Pharmacological Reports

Volumn 60, Issue 4, 2008, Pages 542-548

  Boćkowski, Leszek ^a   Sobaniec, Wojciech ^a   Kułak, Wojciech ^a   Śmigielska Kuzia, Joanna ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Antioxidant enzymes; Headaches; Lipid peroxides; Migraine

Indexed keywords

ANTIOXIDANT; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; MALONALDEHYDE; SUPEROXIDE DISMUTASE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ERYTHROCYTE; FEMALE; HUMAN; LIPID PEROXIDATION; MALE; MIGRAINE WITH AURA; MIGRAINE WITHOUT AURA; MOLECULAR MECHANICS; PATHOPHYSIOLOGY;

EID: 52049127071     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Artemowicz B, Sobaniec W: Investigation of lipid peroxidation and antioxidant enzymes activity in the serum of epileptic children (Polish). Epileptologia, 2001, 9, 167-178.
2. Artemowicz B, Sołowiej E, Sobaniec W: The disturbance of the oxidants-antioxidants balance in epileptic children. Int J Neuroprot Neuroregener, 2004, 1, 27-31.
3. Bisaglia M, Venezia V, Piccioli P, Stanzione S, Porcile C, Russo C, Mancini F et al.: Acetaminophen protects hippocampal neurons and PC12 cultures from amyloid β-peptides induced oxidative stress and reduces NF-κB activation. Neurochem Int, 2002, 41, 43-54.
4. Bolayir E, Celik K, Kugu N: Intraerythrocyte antioxidant enzyme activities in migraine and tension-type headaches. J Chin Med Assoc, 2004, 67, 263-267.
5. Buege JA, Aust SD: Microsomal lipid peroxidation. Methods Enzymol, 1978, 51, 302-310.
6. Chayasirisobhon S: Use of a pine bark extract and antioxidant vitamin combination product as therapy for migraine in patients refractory to pharmacologic medication. Headache, 2006, 46, 788-793.
7. Ciancarelli I, Tozzi-Ciancarelli MG, Di Massmo C, Marini C, Carolei A: Flunarizine effects on oxidative stress in migraine patients. Cephalalgia, 2004, 24, 528-532.
8. Cincarelli I, Tozzi-Ciancarelli MG, Di Massimo C, Marini C, Carolei A: Urinary nitric oxide metabolites and lipid peroxidation by-products in migraine. Cephalalgia, 2003, 23, 39-42.
9. D'Amico D, Ferraris A, Leone M, Catania A, Carlin A, Grazzi I, Bussone G: Increased plasma nitrites in migraine and cluster headache patients in interictal period: basal hyperactivity of L-arginine NO patway? Cephalalgia, 2002, 22, 33-36.
10. Diaz J, Serrano E, Acosta F, Carbopell LF: Reference intervals for four biochemistry analytes in plasma for evaluating oxidative stress and lipid peroxidation in human plasma. Clin Chem, 1998, 44, 2215-2217.
11. Glaubic-Łafka M, Łatka D, Bury W, Pierzchała K: Current opinions on migraine pathophysiology (Polish). Neurol Neurochir Pol, 2004, 38, 307-315.
12. Halliwell B: Free radicals, antioxidants, and human disease: curiosity, cause or consequence? Lancet, 1994, 344, 721-724.
13. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Second edition. Cephalalgia, 2004, Suppl 1, 1-160.
14. Lance J: Current concepts of migraine pathogenesis. Neurology, 1993, 43, 11-15.
15. Maharaj H, Maharaj DS, Daya S: Acetylsalicylic acid and acetaminophen protect against oxidative neurotoxicity. Metab Brain Dis, 2006, 21, 189-199.
16. May A, Goadsby P: Pharmacological opportunities and pitfalls in the therapy of migraine. Curr Opin Neurol, 2001, 14, 341-345.
17. McCord JM: Human disease, free radicals, and the oxidant/antioxidant balance. Clin Biochem, 1993, 26, 351-357.
18. Mize CE, Langdon RG: Hepatic glutathione reductase I. Purification and general kinetic properties. J Biol Chem, 1962, 237, 1589-1595.
19. Moskowitz MA, Buzzi MG, Sakas DE, Linnik MD: Pain mechanisms underlying vascular headaches. Progress Report 1989. Rev Neurol, 1989, 145, 181-193.
20. Nielsen F, Mikkelsen BB, Nielsen JB, Andersen HR, Grandjean P: Plasma malondialdehyde as biomarker for oxidative stress: reference interval and effects of life-style factors. Clin Chem, 1997, 43, 1209-1214.
21. Paglia DE, Valentine WN: Studies on the quantitative and qualitative characterisation of erythrocyte glutatione peroxidase. J Lab Clin Med, 1967, 70, 158-169.
22. Reuter U, Sanchez del Rio M, Moskowitz M: Experimental models of migraine. Funct Neurol, 2000, 15, 9-18.
23. Shimomura T, Kowa H, Nakano T, Kitano A, Marukawa H, Urakami K, Takahashi K: Platelet superoxide dismutase in migraine and tension-type headache. Cephalalgia 1994, 14, 215-218.
24. Shimomura T, Murakami F, Kotani K, Ikawa S, Kono S: Platelet nitric oxide metabolites in migraine. Cephalalgia, 1999, 19, 218-222.
25. Shukla R, Barthwal MK, Srivastava N, Sharma P, Raghavan SAV, Nag D, Srimal DC et al.: Neutrophil-free radical generation and enzymatic antioxidants in migraine patients. Cephalalgia, 2004, 24, 37-43.
26. Sobaniec W, Kułak W, Boćkowski L, Śmigielska-Kuzia J, Sobaniec-Lotowska M, Sołowiej E, Sobaniec H, Artemowicz B: Studies of damage processes of nervous system and possibilities of neuroprotection (Polish). Przegl Lek, 2001, 58, 41-47.
27. Sobaniec W, Sołowiej E, Kułak W, Boćkowski L, Śmigielska-Kuzia J, Artemowicz B: Evaluation of the influence of antiepileptic therapy on antioxidant enzyme activity and lipid peroxidation in erythrocytes of children with epilepsy. Child Neurol, 2006, 21, 558-562.
28. 2A receptor activation and nitric oxide synthesis: a possible mechanism determining migraine attacks. Headache, 2002, 42, 566-574.
29. Stirparo G, Zicari A, Favilla, M, Lipari M, Martelletti M: Linked activation of nitric oxide synthase and cyclooxygenase in peripheral monocytes of asymptomatic migraine without aura patients. Cephalalgia, 2000, 20, 100-106.
30. Sykes JA, McCormack FX, O'Brien TJ: A preliminary study of superoxide dismutase content of some human tumors. Cancer Res, 1978, 38, 2759-2762.
31. Śmigielska-Kuzia J, Sobaniec W, Kułak W, Boćkowski L: Assessment of efficacy of piracetam in comparison with flunarizine in the treatment of migraine and tension-type headaches in children. Neurol Dziec, 2002, 11, 45-58.
32. Tozzi-Ciancarelli MG, DeMatteis G, DiMassimo C, Marini C, Cianearelli I, Carolei A: Oxidative stress and platelet responsiveness in migraine. Cephalalgia, 1997, 17, 580-584.
33. Tuszkiewicz-Misztal E, Opoka-Winiarska V, Postepski J: Significance of dietary antioxidants for child proper development and health (Polish). Pediatr Pol, 2000, 75, 359-366.
34. Wei EP, Kontos HA, Beckman JS: Mechanisms of cerebral vasodilatation by superoxide, hydrogen peroxide, and peroxynitrite. Am J Physiol, 1996, 271, H1262-1266.
35. Welch KM, Nagesh V, Aurora SK, Gelman N: Periaqueductal gray matter dysfunction in migraine: cause or the burden of illness? Headache, 2001, 41, 629-637.
36. Zaremba PD, Białek M, Błaszczyk B, Cichoczek P, Czaczwar J: Non-epilepsy uses of antiepileptic drugs. Pharmacol Rep, 2006, 58, 1-12.